Stories by Jessica Wapner

When criminal behavior overlaps with degenerative cognitive disease, the justice system often falters

Stanford neurobiologist Andrew Huberman discusses the two things we can always control, even during a high-stress election and scary COVID pandemic

Despite progress, genetic profiling of tumors has a long way to go 

It can be performed at a clinic, yield same-day results and may cost less than half the current test

Counterintuitively, key heart health indicators proved markedly better in dogs with pacemakers programmed for a period of irregular contractions

New software and gene analyses may predict which medicines can become harmful when taken together

Large study reveals adolescents from low-income families have more physical and psychological issues

For many liver disease patients, implantation of a few new cells from a healthy organ may buy time or avoid a full transplant altogether

A long, difficult and costly research effort gives doctors a new cure for hepatitis C

A new book tells the tale of Gleevec, a breakthrough treatment that targets cancer at the genetic level

Many hospitals fail to take simple measures to prevent infections of a new strain of Clostridium difficile that's hard to track and at least in part responsible for skyrocketing infection rates in U.S. hospitals

The biomedical evidence for alternative or complementary treatments for cancer, beyond acupuncture, remains thin, although it probably didn't harm Jobs

A giant magnet is illuminating how the influenza A virus mutates to resist drugs

Long-awaited breakthroughs in developing preclinical animal models are signaling a new era for liver-targeted viruses and beyond

The Orphan Drug Act has stimulated research and produced blockbusters like Botox, but interest may be waning

With medical applications for smart phones becoming a more prominent part of doctors' diagnostic tool kits, the FDA is considering how it should regulate the market--if at all

State-legislated programs for the donation of unused drugs have seen limited success

Proponents see hope in changing cancer vaccines' bad reputation

In discussing treatments, cancer doctors plan to include cost

The therapeutic value of blogging becomes a focus of study